Skip to main content
Log in

Das diabetische Fußsyndrom

Diabetic foot syndrome

  • Schwerpunkt
  • Published:
Der Internist Aims and scope Submit manuscript

Zusammenfassung

Das diabetische Fußsyndrom ist weltweit eine der bedeutendsten Komplikationen und häufigste Ursache für die Notwendigkeit einer Krankenhausbehandlung bei Patienten mit einem Diabetes mellitus. Die Ätiologie des diabetischen Fußsyndroms ist multifaktoriell und komplex. Die Pathophysiologie der diabetischen Fußläsion mit Polyneuropathie und Angiopathie sowie Wundheilungsstörungen aufgrund des Diabetes steht hier im Vordergrund. Durch geeignete Behandlungsstrategien sowie interdisziplinäre und sektorenübergreifende Strukturen ist es möglich, in Deutschland die im europäischen Vergleich deutlich höheren Amputationsraten zu senken.

Abstract

Diabetic foot ulceration is a serious complication of diabetes mellitus worldwide and the most common cause of hospitalization in diabetic patients. The etiology of diabetic foot ulcerations is complex due to their multifactorial nature. The pathophysiologies of diabetic foot ulceration with polyneuropathy and angiopathy as well as wound-healing impairment in patients with diabetes mellitus are important. Proper adherence to standard treatment strategies and interdisciplinary cooperation can reduce the – compared with European data – noticeable higher rates of major amputations in Germany.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Adler A (2001) Risk factors for diabetic neuropathy and foot ulceration. Curr Diab Rep 1:202–207

    Article  PubMed  CAS  Google Scholar 

  2. Ambrosch A, Lehnert H, Lobmann R (2003) Microbiological aspects and antibiotic therapy of diabetic foot infections. Med Klin (Munich) 98:259–265

    Google Scholar 

  3. Ambrosch A, Lobmann R, Pott A, Preissler J (2008) Interleukin-6 concentrations in wound fluids rather than serological markers are useful in assessing bacterial triggers of ulcer inflammation. Int Wound J 5:99–106

    Article  PubMed  Google Scholar 

  4. Armstrong DG, Jude EB (2002) The role of matrix metalloproteinases in wound healing. J Am Podiatr Med Assoc 92:12–18

    PubMed  Google Scholar 

  5. Armstrong DG, Lavery LA, Harkless LB (1998) Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 21:855–859

    Article  PubMed  CAS  Google Scholar 

  6. Armstrong DG, Peters EJ (2001) Classification of wounds of the diabetic foot. Curr Diab Rep 1:233–238

    Article  PubMed  CAS  Google Scholar 

  7. Barker AR, Rosson GD, Dellon AL (2006) Wound healing in denervated tissue. Ann Plast Surg 57:339–342

    Article  PubMed  CAS  Google Scholar 

  8. Bentley J, Foster A (2007) Multidisciplinary management of the diabetic foot ulcer. Br J Community Nurs 12:S6, S8, S10

    PubMed  Google Scholar 

  9. Boulton AJ (2008) The diabetic foot: grand overview, epidemiology and pathogenesis. Diabetes Metab Res Rev 24 (Suppl 1):S3–S6

    Article  PubMed  Google Scholar 

  10. Boulton AJ, Kirsner RS, Vileikyte L (2004) Clinical practice. Neuropathic diabetic foot ulcers. N Engl J Med 351:48–55

    Article  PubMed  CAS  Google Scholar 

  11. Bus SA, Valk GD, Deursen RW van et al (2008) The effectiveness of footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in diabetes: a systematic review. Diabetes Metab Res Rev 24 (Suppl 1):S162–S180

    Article  PubMed  Google Scholar 

  12. Cavanagh PR, Bus SA (2011) Off-loading the diabetic foot for ulcer prevention and healing. Plast Reconstr Surg 127 (Suppl 1):248S–256S

    Article  PubMed  CAS  Google Scholar 

  13. da Silva L, Carvalho E, Cruz MT (2010) Role of neuropeptides in skin inflammation and its involvement in diabetic wound healing. Expert Opin Biol Ther 10:1427–1439

    Article  Google Scholar 

  14. Davis SC, Martinez L, Kirsner R (2006) The diabetic foot: the importance of biofilms and wound bed preparation. Curr Diab Rep 6:439–445

    Article  PubMed  CAS  Google Scholar 

  15. Edmonds ME, Foster AV (2006) Diabetic foot ulcers. BMJ 332:407–410

    Article  PubMed  Google Scholar 

  16. Edwards J, Stapley S (2010) Debridement of diabetic foot ulcers. Cochrane Database Syst Rev:CD003556

    Google Scholar 

  17. Eneroth M, Houtum WH van (2008) The value of debridement and Vacuum-Assisted Closure (V.A.C.) therapy in diabetic foot ulcers. Diabetes Metab Res Rev 24 (Suppl 1):S76–S80

    Article  PubMed  Google Scholar 

  18. Fard AS, Esmaelzadeh M, Larijani B (2007) Assessment and treatment of diabetic foot ulcer. Int J Clin Pract 61:1931–1938

    Article  PubMed  CAS  Google Scholar 

  19. Frykberg RG (1998) The team approach in diabetic foot management. Adv Wound Care 11:71–77

    PubMed  CAS  Google Scholar 

  20. Gardner SE, Frantz RA (2008) Wound bioburden and infection-related complications in diabetic foot ulcers. Biol Res Nurs 10:44–53

    Article  PubMed  Google Scholar 

  21. Gilbey SG (2004) Neuropathy and foot problems in diabetes. Clin Med 4:318–323

    PubMed  CAS  Google Scholar 

  22. Graiani G, Emanueli C, Desortes E et al (2004) Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of type 1 diabetic mice. Diabetologia 47:1047–1054

    Article  PubMed  CAS  Google Scholar 

  23. Hochlenert D, Engels G (2007) Integrated management in patients with diabetic foot syndrome. MMW Fortschr Med 149:41–43

    PubMed  CAS  Google Scholar 

  24. Kalish J, Hamdan A (2009) Management of diabetic foot problems. J Vasc Surg 51:476–486

    Article  PubMed  Google Scholar 

  25. Kalish J, Hamdan A (2010) Management of diabetic foot problems. J Vasc Surg 51:476–486

    Article  PubMed  Google Scholar 

  26. Karthikesalingam A, Holt PJ, Moxey P et al (2010) A systematic review of scoring systems for diabetic foot ulcers. Diabet Med 27:544–549

    Article  PubMed  CAS  Google Scholar 

  27. Lawall H, Reike H (2009) Diabetic foot syndrome. Internist (Berl) 50:936–944

    Google Scholar 

  28. Lobmann R, Müller E, Bergmann K et al (2007) The diabetic foot in Germany: Analysis of quality in specialised diabetic wound care centers. Diabetic Foot J 10:68–72

    Google Scholar 

  29. Lobmann R, Müller E, Gröne C, Kersken J (2010) The diabetic foot in Germany: Analysis of quality in specialised diabetic foot care centers. Diabetologia 53 (Suppl 1): 56

    Google Scholar 

  30. Lobmann R, Schultz G, Lehnert H (2005) Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care 28:461–471

    Article  PubMed  CAS  Google Scholar 

  31. Lobmann R, Zemlin C, Motzkau M (2006) Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing. J Diabetes Complications 20:329–335

    Article  PubMed  Google Scholar 

  32. Molines L, Darmon P, Raccah D (2010) Charcot’s foot: newest findings on its pathophysiology, diagnosis and treatment. Diabetes Metab 36:251–255

    Article  PubMed  CAS  Google Scholar 

  33. Morbach S, Müller E, Reike H (2009) Diabetisches Fussyndrom. Diabetol Stoffw 4:157–165

    Article  Google Scholar 

  34. Muangman P, Muffley LA, Anthony JP et al (2004) Nerve growth factor accelerates wound healing in diabetic mice. Wound Repair Regen 12:44–52

    Article  PubMed  Google Scholar 

  35. Ndip A, Bowling F, Stickings D (2008) The diabetic foot in 2008: an update from the 12th Malvern Diabetic Foot Meeting. Int J Low Extrem Wounds 7:235–238

    Article  PubMed  Google Scholar 

  36. Rathur HM, Boulton AJ (2007) The neuropathic diabetic foot. Nat Clin Pract Endocrinol Metab 3:14–25

    Article  PubMed  Google Scholar 

  37. Reike H, Angelkort B (1999) Structures for treatment of patients with diabetic foot syndrome. Internist (Berl) 40:1072–1076

    Google Scholar 

  38. Risse A (2007) The diabetic foot syndrome – an interdisciplinary challenge. Hamostaseologie 27:117–122

    PubMed  CAS  Google Scholar 

  39. Rumenapf G, Dittler S, Morbach S et al (2008) The vascular surgeon’s role in interdisciplinary treatment of diabetic foot syndrome. Chirurgia 79:535–545

    Article  CAS  Google Scholar 

  40. Schaper NC, Nabuurs-Franssen MH (2002) The diabetic foot: pathogenesis and clinical evaluation. Semin Vasc Med 2:221–228

    Article  PubMed  CAS  Google Scholar 

  41. Urbancic-Rovan V (2005) Causes of diabetic foot lesions. Lancet 366:1675–1676

    Article  PubMed  Google Scholar 

  42. van Battum P, Schaper N, Prompers L et al (2011) Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation. Diabet Med 28:199–205

    Article  Google Scholar 

  43. Wallace GF (2007) Debridement of invasive diabetic foot infections. Clin Plast Surg 34:731–734

    Article  PubMed  Google Scholar 

  44. Wukich DK (2010) Current concepts review: diabetic foot ulcers. Foot Ankle Int 31:460–467

    Article  PubMed  Google Scholar 

  45. Zimmermann A, Reeps C, Hartl F et al (2009) The diabetic foot. Chirurgia 80:430–436

    Article  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor weist auf folgende Beziehungen hin:

Referententätigkeit und Forschungsförderdung der Firmen Novartis und Bayer.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Lobmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lobmann, R. Das diabetische Fußsyndrom. Internist 52, 539–548 (2011). https://doi.org/10.1007/s00108-010-2733-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-010-2733-z

Schlüsselwörter

Keywords

Navigation